Evaluation of risk factors associated with clinical improvement and survival of horses with equine protozoal myeloencephalitis.
Abstract: To investigate risk factors for use in predicting clinical improvement and survival of horses with equine protozoal myeloencephalitis (EPM). Methods: Longitudinal epidemiologic study. Methods: 251 horses with EPM. Methods: Between 1992 and 1995, 251 horses with EPM were admitted to our facility. A diagnosis of EPM was made on the basis of neurologic abnormalities and detection of antibody to Sarcocystis neurona or S neurona DNA in CSF. Data were obtained from hospital records and through telephone follow-up interviews. Factors associated with clinical improvement and survival were analyzed, using multivariable logistic regression. Results: The likelihood of clinical improvement after diagnosis of EPM was lower in horses used for breeding and pleasure activities. Treatment for EPM increased the probability that a horse would have clinical improvement. The likelihood of survival among horses with EPM was lower among horses with more severe clinical signs and higher among horses that improved after EPM was diagnosed. Conclusions: Treatment of horses with EPM is indicated in most situations; however, severity of clinical signs should be taken into consideration when making treatment decisions. Response to treatment is an important indicator of survival.
Publication Date: 2000-10-24 PubMed ID: 11043689DOI: 10.2460/javma.2000.217.1181Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study investigates the risk factors determining clinical improvement and survival rates in horses diagnosed with equine protozoal myeloencephalitis (EPM). Findings reveal that treatment generally enhances chances of clinical improvement, particularly where early detection occurs; however, severity of clinical signs and usage of the horse also influence likely outcomes.
Study Methodology
- The research was a longitudinal epidemiologic study, conducted between 1992 and 1995, involving 251 horses diagnosed with EPM. The diagnosis was based on neurological abnormalities and the detection of antibody to Sarcocystis neurona (S neurona) or its DNA in cerebrospinal fluid (CSF).
- Researchers gathered data from hospital records and through follow-up interviews conducted over the phone.
- A multivariable logistic regression was employed to analyze factors associated with clinical improvement and survival among the horses.
Key Findings
- One significant finding was that horses used for breeding and pleasure were less likely to show clinical improvement following an EPM diagnosis, suggesting that usage of the animal can influence disease prognosis.
- Administering treatment for EPM increases the probability of clinical improvement in the horse. Therefore, treatment is generally advisable in most situations.
- The likelihood of survival decreased among horses with severe clinical symptoms, and conversely, horses that responded positively to treatment and showed clinical improvement were more likely to survive. The severity of the clinical signs is therefore an important consideration in treatment decisions.
Conclusion
- Treatment of EPM can increase survival and promote clinical improvement, making it a recommended procedure in dealing with the disease.
- However, factors such as the severity of clinical signs should be taken into account when deciding on the treatment approach. In severe cases, prognosis might be more challenging.
- The researchers highlight the importance of monitoring a horse’s response to treatment, as a positive response is a significant indicator of potential survival.
Cite This Article
APA
Saville WJ, Morley PS, Reed SM, Granstrom DE, Kohn CW, Hinchcliff KW, Wittum TE.
(2000).
Evaluation of risk factors associated with clinical improvement and survival of horses with equine protozoal myeloencephalitis.
J Am Vet Med Assoc, 217(8), 1181-1185.
https://doi.org/10.2460/javma.2000.217.1181 Publication
Researcher Affiliations
- Department of Veterinary Preventive Medicine, College of Veterinary Medicine, The Ohio State University, Columbus 43210, USA.
MeSH Terms
- Animals
- Central Nervous System Protozoal Infections / mortality
- Central Nervous System Protozoal Infections / therapy
- Central Nervous System Protozoal Infections / veterinary
- Encephalomyelitis / mortality
- Encephalomyelitis / therapy
- Encephalomyelitis / veterinary
- Female
- Horse Diseases / mortality
- Horse Diseases / therapy
- Horses
- Longitudinal Studies
- Male
- Prognosis
- Retrospective Studies
- Risk Factors
- Sarcocystosis / mortality
- Sarcocystosis / therapy
- Sarcocystosis / veterinary
- Survival Analysis
Citations
This article has been cited 2 times.- Reed SM, Furr M, Howe DK, Johnson AL, MacKay RJ, Morrow JK, Pusterla N, Witonsky S. Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.. J Vet Intern Med 2016 Mar-Apr;30(2):491-502.
- Dubey JP, Howe DK, Furr M, Saville WJ, Marsh AE, Reed SM, Grigg ME. An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).. Vet Parasitol 2015 Apr 15;209(1-2):1-42.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists